Literature DB >> 4909796

Treatment of phobic states with antidepressants. A retrospective study of 246 patients.

D Kelly, W Guirguis, E Frommer, N Mitchell-Heggs, W Sargant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4909796     DOI: 10.1192/bjp.116.533.387

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  12 in total

Review 1.  Anxiety and drug therapy.

Authors:  D Kelly
Journal:  Proc R Soc Med       Date:  1973-03

2.  Some approaches to the treatment of phobic disorders.

Authors:  R Gaind; J P Watson; I M Marks
Journal:  Proc R Soc Med       Date:  1971-11

3.  Application of Pavlovian concepts to anxiety and forearm blood flow.

Authors:  D Kelly
Journal:  Cond Reflex       Date:  1969 Oct-Dec

Review 4.  Overview of panic disorder.

Authors:  J C Ballenger
Journal:  Trans Am Clin Climatol Assoc       Date:  1994

5.  Phenelzine in phobic states.

Authors:  D Kelly
Journal:  Proc R Soc Med       Date:  1973-09

Review 6.  The utility of the panic disorder concept.

Authors:  D F Klein; H M Klein
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

Review 7.  A risk-benefit assessment of buspirone in the treatment of anxiety disorders.

Authors:  J C Pecknold
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

8.  Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

Authors:  D J Fontana; T J Carbary; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.

Authors:  J A Den Boer; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.

Authors:  I M van Vliet; H G Westenberg; J A Den Boer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.